Aurobindo Pharma Ltd. Reports 26% YoY Growth
Aurobindo Pharma Ltd on Wednesday reported a 26 percent increase in consolidated net profit at Rs 805.65 crore in the second quarter ended September.The company...
Tag : biosimilar
Lupin’s biosimilar Etanercept accepted for review, by EMA
Lupin’s marketing authorization application (MAA) for biosimilar Etanercept has been accepted for review by Europe drug regulator, European Medicines Agency (EMA). MAA means an application submitted by...
Glenmark introduces biosimilar of Adalimumab
Glenmark Pharmaceuticals, for treating plaque psoriasis and rheumatoid arthritis in the country, has announced the launch of Adalimumab’s biosimilar under a licensing agreement with Zydus group firm...
Mylan-Biocon’s breast cancer biosimilar receives ANVISA approval
Biocon and Mylan’s proposed trastuzumab has received approval from Brazilian regulatory agency ANVISA, through their partner Libbs Farmaceutica (Libbs). The approved product is co-developed by Biocon...